Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics (NQ: RVNC ) 5.810 +0.010 (+0.17%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results May 10, 2024 Via Benzinga RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 RVNC stock results show that Revance Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update May 09, 2024 From Revance Therapeutics, Inc. Via Business Wire Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia May 09, 2024 From Revance Therapeutics, Inc. Via Business Wire Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 May 02, 2024 From Revance Therapeutics, Inc. Via Business Wire Earnings Outlook For Revance Therapeutics February 27, 2024 Via Benzinga Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting April 12, 2024 From Revance Therapeutics, Inc. Via Business Wire BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday April 09, 2024 U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. Via Benzinga Topics Stocks Exposures US Equities Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 27, 2024 From Revance Therapeutics, Inc. Via Business Wire GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session March 11, 2024 U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdings Limited (NASDAQ: GDS) shares rose sharply in today’s pre-market trading. Via Benzinga Topics Stocks Exposures US Equities Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 04, 2024 Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... Via Benzinga Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday March 04, 2024 U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Revance Announces Pricing of $100.0 Million Public Offering of Common Stock March 04, 2024 From Revance Therapeutics, Inc. Via Business Wire Revance Announces Proposed Public Offering of Common Stock March 04, 2024 From Revance Therapeutics, Inc. Via Business Wire Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 29, 2024 Via Benzinga Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday February 29, 2024 U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update February 28, 2024 From Revance Therapeutics, Inc. Via Business Wire Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 February 21, 2024 From Revance Therapeutics, Inc. Via Business Wire Earnings Scheduled For February 28, 2024 February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. Via Benzinga Revance to Participate in Upcoming Investor Conferences February 21, 2024 From Revance Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session February 02, 2024 Via Benzinga Revance Receives Permanent J-Code for DAXXIFY® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology® February 02, 2024 From Revance Therapeutics, Inc. Via Business Wire Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference February 01, 2024 From Revance Therapeutics, Inc. Via Business Wire Philips Reports Q4 Results, Joins Ryanair And Other Big Stocks Moving Lower In Monday's Pre-Market Session January 29, 2024 U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition January 11, 2024 AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Monday's Intraday Session January 08, 2024 Via Benzinga Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday January 08, 2024 U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft... Via Benzinga Topics Stocks Exposures US Equities Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... Via Benzinga Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook January 08, 2024 From Revance Therapeutics, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
